基本信息
浏览量:4
职业迁徙
个人简介
Dr Ovchinnikov has been involved in research using the cutting-edge approaches of molecular genetics for over two decades and has substantial experience in all aspects of the establishment and use of novel pluripotent stem cell-based molecular genetic reagents and systems, including specifically for human neurodegenerative disease modelling and therapeutic development.
In recent years Dr Ovchinnikov developed numerous targeted transgenic hPSC lines, including many using safe harbour sites to ensure uniform and sustained expression, critical in a neurodegenerative disease research setting. He has also developed reporters of gene and cellular processes activities, as well as resources for functional genomics (gene expression manipulation).
Dr Ovchinnikov has been an active member of the key international stem cell research-coordinating International Society for Stem Cell Research, he is on the abstract reviewing panel for annual meetings of the Society and presented at two of those. He has also been instrumental in introducing genetically modified cell lines as the new and ever-growing stem cell resource publication format as an editor at Stem Cell Research (Elsevier B.V.), the main forum for this type of scientific communications.
In the last 5 years, Dr Ovchinnikov published 9 papers in this field (4 as first, 2 sole, 1 as a senior author), many in top-tier stem cell journals. Overall, he published over 60 articles with over 8700 total citations (with 5 as a sole/first author with >100 citations), including many in top journals (e.g. Nature, Science, Nature Genetics, Cell Stem Cell, PNAS), and has an h index of 29, i10-index 44, holds international/US patents on the detection of epigenetic changes associated with some common cancers. He attracted over 4M AUD in research and infrastructure funding from various bodies, including the National Health & Medical Research Council, Medical Research Futures Fund & Stem Cells Australia, and National Critical Research Infrastructure Scheme / BioPlatfoms – Australia, as well as local schemes from universities and private donors. Dr Ovchinnikov recently secured a novel ataxia ASO treatment-focused grant from the US funding body.
In recent years Dr Ovchinnikov developed numerous targeted transgenic hPSC lines, including many using safe harbour sites to ensure uniform and sustained expression, critical in a neurodegenerative disease research setting. He has also developed reporters of gene and cellular processes activities, as well as resources for functional genomics (gene expression manipulation).
Dr Ovchinnikov has been an active member of the key international stem cell research-coordinating International Society for Stem Cell Research, he is on the abstract reviewing panel for annual meetings of the Society and presented at two of those. He has also been instrumental in introducing genetically modified cell lines as the new and ever-growing stem cell resource publication format as an editor at Stem Cell Research (Elsevier B.V.), the main forum for this type of scientific communications.
In the last 5 years, Dr Ovchinnikov published 9 papers in this field (4 as first, 2 sole, 1 as a senior author), many in top-tier stem cell journals. Overall, he published over 60 articles with over 8700 total citations (with 5 as a sole/first author with >100 citations), including many in top journals (e.g. Nature, Science, Nature Genetics, Cell Stem Cell, PNAS), and has an h index of 29, i10-index 44, holds international/US patents on the detection of epigenetic changes associated with some common cancers. He attracted over 4M AUD in research and infrastructure funding from various bodies, including the National Health & Medical Research Council, Medical Research Futures Fund & Stem Cells Australia, and National Critical Research Infrastructure Scheme / BioPlatfoms – Australia, as well as local schemes from universities and private donors. Dr Ovchinnikov recently secured a novel ataxia ASO treatment-focused grant from the US funding body.
研究兴趣
论文共 78 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Stem Cell Research (2024): 103407-103407
Stem cell research (2023): 103179-103179
Timothy J. Tracey,Leanne Jiang, Melinder K. Gill,Samara N. Ranie,Dmitry A. Ovchinnikov,Ernst J. Wolvetang,Shyuan T. Ngo
Stem Cell Research (2023): 103137-103137
Cell stem cellno. 3 (2022): 434-448.e5
semanticscholar(2021)
Dmitry A Ovchinnikov,Sarah L Withey,Hannah C Leeson, U Wang Lei, Ashmitha Sundarrajan, Keerat Junday,Michelle Pewarchuk,Abrey J Yeo,Amanda W Kijas,Martin F Lavin,Ernst J Wolvetang
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn